Arena Pharmaceuticals, Inc. (ARNA): One Mind-Blowing Metric Screaming ‘Buy’

Page 2 of 2

With the returns shown by the aforementioned tactics, everyday investors must always pay attention to hedge fund and insider trading sentiment, and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds
1

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Charles River Laboratories (NYSE:CRL) 20 0 7
Synageva BioPharma Corp (NASDAQ:GEVA) 6 3 5
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) 10 1 6
Viropharma Inc (NASDAQ:VPHM) 20 1 5
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) 21 2 2
Page 2 of 2